CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 1,385 shares at $6.73 ($9,321)
- 4 Open-market sale SEE REMARKS sold 1,617 shares at $6.74 ($10,899)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 4,539 shares at $6.73 ($30,547)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,227 shares at $6.74 ($8,270)
- 4 Open-market sale SEE REMARKS sold 1,405 shares at $6.74 ($9,470)
- 4 Grant or award Director acquired 4,792 shares (grant or award)
- 4 Grant or award Director acquired 4,884 shares (grant or award)
- 4 Grant or award Director acquired 8,915 shares (grant or award)
- 4 Grant or award Director acquired 9,088 shares (grant or award)
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 36,847 shares (grant or award)
- 4 Grant or award Director acquired 6,956 shares (grant or award)
- 4 Grant or award SEE REMARKS acquired 37,559 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 36,144 shares (grant or award)
- 4 Grant or award SEE REMARKS acquired 49,356 shares (grant or award)
- 4 Grant or award SEE REMARKS acquired 48,698 shares (grant or award)
- 4 Grant or award Director acquired 4,884 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 158,873 shares (grant or award)
- 4 Grant or award Director acquired 2,502 shares (grant or award)
- 4 Grant or award Director acquired 1,600 shares (grant or award)
- 4 Grant or award CHIEF BUSINESS OFFICER acquired 9,625 shares (grant or award)
Page 4 of 15 · 288 filings